Secondary acute myeloid leukemia after treatment of acute monoblastic leukemia [4]

New England Journal of Medicine

Volumn 343, Issue 25, 2000, Pages 1897-1898

  Kebelmann Betzing, C ^a   Seeger, K ^a   Kulozik, A ^a   Henze, G ^a   Liehr, T ^a   Heller, A ^a   Teigler Schlegel, A ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; IDARUBICIN; MITOXANTRONE; PREDNISONE; TIOGUANINE; VINCRISTINE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE MONOCYTIC LEUKEMIA; ADULT; CASE REPORT; CHILDHOOD LEUKEMIA; CHROMOSOME TRANSLOCATION; CYTOGENETICS; FEMALE; HUMAN; KARYOTYPE; LETTER; PRIORITY JOURNAL; RELAPSE;

ACUTE DISEASE; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DIAGNOSIS, DIFFERENTIAL; FATAL OUTCOME; FEMALE; HUMANS; LEUKEMIA, MONOCYTIC, ACUTE; LEUKEMIA, MYELOID; NEOPLASMS, SECOND PRIMARY;

EID: 0034700440     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200012213432515     Document Type: Letter

References (5)

1. Incidence of secondary acute myelogenous leukemia after treatment of childhood acute lymphoblastic leukemia
2. Secondary acute myeloid leukemia following treatment with VP16-containing regimens for non-Hodgkin's lymphoma
3. Hodgkin's disease and the risk of acute leukemia in successfully treated patients
4. Cytogenetic and molecular delineation of the smallest commonly deleted region of chromosome 5 in malignant myeloid diseases
5. Therapy-related myelodysplastic syndrome and acute myeloid leukemia with 17p deletion: A report on 25 cases